Show simple item record

dc.contributor.authorThöne, Kathrin
dc.contributor.authorHorn, Johannes
dc.contributor.authorMikolajczyk, Rafael T
dc.date.accessioned2017-09-11T11:46:45Z
dc.date.available2017-09-11T11:46:45Z
dc.date.issued2017-08-14
dc.identifier.citationEvaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data. 2017, 17 (1):564 BMC Infect. Dis.en
dc.identifier.issn1471-2334
dc.identifier.pmid28806926
dc.identifier.doi10.1186/s12879-017-2663-7
dc.identifier.urihttp://hdl.handle.net/10033/621101
dc.description.abstractShortly after the human papillomavirus (HPV) vaccine recommendation and hence the reimbursement of vaccination costs for the respective age groups in Germany in 2007, changes in the incidence of anogenital warts (AGWs) were observed, but it was not clear at what level the incidence would stabilize and to what extent herd immunity would be present. Given the relatively low HPV vaccination coverage in Germany, we aimed to assess potential vaccination herd immunity effects in the German setting.
dc.language.isoenen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleEvaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.en
dc.typeArticleen
dc.contributor.departmentHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalBMC infectious diseasesen
refterms.dateFOA2018-06-12T21:51:28Z
html.description.abstractShortly after the human papillomavirus (HPV) vaccine recommendation and hence the reimbursement of vaccination costs for the respective age groups in Germany in 2007, changes in the incidence of anogenital warts (AGWs) were observed, but it was not clear at what level the incidence would stabilize and to what extent herd immunity would be present. Given the relatively low HPV vaccination coverage in Germany, we aimed to assess potential vaccination herd immunity effects in the German setting.


Files in this item

Thumbnail
Name:
Thöne,Horn and Mikolajcyck.pdf
Size:
1.075Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/